Rahuel C, London J, Vignal A, Cherif-Zahar B, Colin Y, Siebert P, Fukuda M, Cartron J P
Unité 76 de l'Institut National de la Santé et de la Recherche Médicale, Institut National de Transfusion Sanguine, Paris, France.
Eur J Biochem. 1988 Nov 15;177(3):605-14. doi: 10.1111/j.1432-1033.1988.tb14413.x.
Glycophorins A and B are homologous glycoproteins of the red cell membrane which carry the blood-group MN and Ss antigens, respectively, and are encoded by two distinct genes closely linked on chromosome 4, which are probably derived from each other by duplication during evolution. The lack of glycophorin A is associated with the rare phenotype En(a-), indicating individuals who are defective for MN antigens, as well as for the Ena antigens, also located on this glycoprotein. The En(a-) condition is heterogenous and includes two categories of variants exemplified by the Finnish and the English types referred to as En(Fin) and En(UK), respectively. By Southern blot and preliminary genomic clone analyzes we have compared the status of the genes for glycophorins A and B, as well as that of the gene encoding glycophorin C, another unrelated red cell membrane glycoprotein, in the En(a-) variants and in the En(a+) control donors. Our data indicate that the En(Fin) variant is homozygous for a complete deletion of the glycophorin A gene without any detectable abnormality of the genes encoding glycophorins B or C. In the genome of the En(UK) variant, with the presumed genotype Mk/En(UK), and where the Mk condition abolishes the expression of MN and Ss antigens, we have identified several abnormalities of the glycophorin A and B genes, but the glycophorin C gene was unaffected. Our results strongly support the view that in Mk chromosome the glycophorin A and B genes are largely deleted, whereas the En(UK) chromosome probably contains a gene fusion product encoding a hybrid glycoprotein AM-B, composed of the N-terminal portion of a blood group M-type glycophorin A and of the C-terminal portion of glycophorin B. The determination of the 5' and 3' limits of the hybrid gene and elucidation of the mechanism involved will require sequencing of the rearranged DNA of the variant and a full knowledge of the organization of the glycophorin A and B genes.
血型糖蛋白A和B是红细胞膜的同源糖蛋白,分别携带MN和Ss血型抗原,由紧密连锁在4号染色体上的两个不同基因编码,这两个基因可能是在进化过程中通过复制彼此衍生而来。缺乏血型糖蛋白A与罕见的En(a-)表型相关,这表明个体的MN抗原以及同样位于该糖蛋白上的Ena抗原存在缺陷。En(a-)情况是异质性的,包括两类变体,分别以芬兰型和英国型为例,称为En(Fin)和En(UK)。通过Southern印迹和初步的基因组克隆分析,我们比较了En(a-)变体和En(a+)对照供体中血型糖蛋白A和B基因以及编码血型糖蛋白C(另一种不相关的红细胞膜糖蛋白)的基因的状态。我们的数据表明,En(Fin)变体是血型糖蛋白A基因完全缺失的纯合子,而编码血型糖蛋白B或C的基因没有任何可检测到的异常。在En(UK)变体的基因组中,推测基因型为Mk/En(UK),其中Mk情况消除了MN和Ss抗原的表达,我们已经鉴定出血型糖蛋白A和B基因的几个异常,但血型糖蛋白C基因未受影响。我们的结果有力地支持了这样一种观点,即在Mk染色体中,血型糖蛋白A和B基因大部分被删除,而En(UK)染色体可能包含一个编码杂合糖蛋白AM-B的基因融合产物,该杂合糖蛋白由血型M型糖蛋白A的N末端部分和血型糖蛋白B的C末端部分组成。确定杂合基因的5'和3'边界以及阐明所涉及的机制将需要对变体的重排DNA进行测序,并全面了解血型糖蛋白A和B基因的组织情况。